Abstract
Background: There is limited knowledge about prognosis of selected breast cancer subtypes among very young women. Patients and methods: We explored patterns of recurrence by age according to four immunohistochemically defined tumor subtypes: Luminal A and Luminal B (estrogen receptor positive and/or progesterone receptor positive and either human epidermal growth factor receptor 2 (HER2) positive and/or high Ki-67), HER2-positive (and) endocrine receptor absent and Triple Negative, in 2970 premenopausal patients with pT1-3, pN0-3 and M0 breast cancer. Results: Patients
| Original language | English |
|---|---|
| Pages (from-to) | 1974-1981 |
| Number of pages | 8 |
| Journal | Annals of Oncology |
| Volume | 21 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Mar 23 2010 |
Fingerprint
Keywords
- Adjuvant therapy
- Breast cancer
- Prognostic features
- Very young women
ASJC Scopus subject areas
- Oncology
- Hematology
Cite this
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (. / Cancello, G.; Maisonneuve, P.; Rotmensz, N.; Viale, G.; Mastropasqua, M. G.; Pruneri, G.; Veronesi, P.; Torrisi, R.; Montagna, E.; Luini, A.; Intra, M.; Gentilini, O.; Ghisini, R.; Goldhirsch, A.; Colleoni, M.
In: Annals of Oncology, Vol. 21, No. 10, 23.03.2010, p. 1974-1981.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (
AU - Cancello, G.
AU - Maisonneuve, P.
AU - Rotmensz, N.
AU - Viale, G.
AU - Mastropasqua, M. G.
AU - Pruneri, G.
AU - Veronesi, P.
AU - Torrisi, R.
AU - Montagna, E.
AU - Luini, A.
AU - Intra, M.
AU - Gentilini, O.
AU - Ghisini, R.
AU - Goldhirsch, A.
AU - Colleoni, M.
PY - 2010/3/23
Y1 - 2010/3/23
N2 - Background: There is limited knowledge about prognosis of selected breast cancer subtypes among very young women. Patients and methods: We explored patterns of recurrence by age according to four immunohistochemically defined tumor subtypes: Luminal A and Luminal B (estrogen receptor positive and/or progesterone receptor positive and either human epidermal growth factor receptor 2 (HER2) positive and/or high Ki-67), HER2-positive (and) endocrine receptor absent and Triple Negative, in 2970 premenopausal patients with pT1-3, pN0-3 and M0 breast cancer. Results: Patients
AB - Background: There is limited knowledge about prognosis of selected breast cancer subtypes among very young women. Patients and methods: We explored patterns of recurrence by age according to four immunohistochemically defined tumor subtypes: Luminal A and Luminal B (estrogen receptor positive and/or progesterone receptor positive and either human epidermal growth factor receptor 2 (HER2) positive and/or high Ki-67), HER2-positive (and) endocrine receptor absent and Triple Negative, in 2970 premenopausal patients with pT1-3, pN0-3 and M0 breast cancer. Results: Patients
KW - Adjuvant therapy
KW - Breast cancer
KW - Prognostic features
KW - Very young women
UR - http://www.scopus.com/inward/record.url?scp=77957110787&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77957110787&partnerID=8YFLogxK
U2 - 10.1093/annonc/mdq072
DO - 10.1093/annonc/mdq072
M3 - Article
C2 - 20332136
AN - SCOPUS:77957110787
VL - 21
SP - 1974
EP - 1981
JO - Annals of Oncology
JF - Annals of Oncology
SN - 0923-7534
IS - 10
ER -